Alvotech (ALVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALVO | AMGN | BMY | GILD | VRTX |
| Company | Alvotech | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 12.67 | 261.10 | 57.65 | 93.43 | 405.26 |
| High | 12.69 | 263.50 | 58.38 | 94.38 | 410.98 |
| Low | 12.50 | 260.51 | 57.52 | 93.43 | 404.49 |
| Last | 12.64 | 262.66 | 57.68 | 93.89 | 408.02 |
| Change | +0.04 | -0.52 | -0.32 | -0.52 | -2.63 |
| % Change | +0.32% | -0.20% | -0.55% | -0.55% | -0.64% |
| Volume | 60,890 | 896,566 | 3,617,156 | 1,468,712 | 840,462 |
| 20-Day Average Volume | 146,497 | 3,943,046 | 11,070,514 | 6,892,014 | 1,815,677 |
| Previous Close | 12.60 | 263.18 | 58.00 | 94.41 | 410.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.88 | 270.34 | 57.75 | 92.54 | 446.42 |
| 20-Day Raw Stochastic | 93.96% | 33.50% | 53.58% | 90.73% | 32.06% |
| 20-Day Relative Strength | 59.24% | 33.05% | 53.75% | 58.33% | 34.77% |
| Weighted Alpha | +6.06 | -15.06 | +20.47 | +26.44 | -7.49 |
| Today's Opinion | 24% Buy | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 24% Buy | 88% Sell | 96% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 56% Sell | 72% Sell | 100% Buy | 96% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.05% since 12/19/24 | +0.87% since 12/19/24 | +2.57% since 12/19/24 | +3.35% since 12/19/24 | +3.23% since 12/19/24 |
| Low | 11.70 on 12/20/24 | 260.51 on 12/27/24 | 56.08 on 12/20/24 | 90.71 on 12/20/24 | 386.49 on 12/20/24 |
| High | 12.69 on 12/27/24 | 269.61 on 12/20/24 | 58.38 on 12/27/24 | 94.55 on 12/26/24 | 411.29 on 12/26/24 |
| 1-Month | |||||
| %Chg | +7.88% since 11/27/24 | -5.93% since 11/27/24 | -2.57% since 11/27/24 | +1.87% since 11/27/24 | -11.86% since 11/27/24 |
| Low | 11.20 on 12/10/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 12.69 on 12/27/24 | 283.64 on 11/29/24 | 60.09 on 12/03/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +5.88% since 09/27/24 | -18.35% since 09/27/24 | +13.43% since 09/27/24 | +12.59% since 09/27/24 | -11.54% since 09/27/24 |
| Low | 9.15 on 10/17/24 | 253.30 on 12/19/24 | 51.03 on 09/30/24 | 82.82 on 10/01/24 | 377.85 on 12/19/24 |
| High | 13.30 on 10/31/24 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +5.00% since 06/27/24 | -16.01% since 06/27/24 | +39.11% since 06/27/24 | +36.77% since 06/27/24 | -13.34% since 06/27/24 |
| Low | 9.15 on 10/17/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 13.30 on 10/31/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,798,673 | 141,467,936 | 117,634,272 | 117,659,984 | 105,754,280 |
| Shares Outstanding, K | 301,482 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 91,430,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -551,730,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 102,990,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -11,390,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | -0.15 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.19 on 11/13/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/13/24 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.76 | 49.37 | 21.21 | 0.00 |